Channel Therapeutics Statistics
Total Valuation
CHRO has a market cap or net worth of $9.58 million. The enterprise value is $12.04 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRO has 6.03 million shares outstanding. The number of shares has increased by 336.69% in one year.
| Current Share Class | 6.03M |
| Shares Outstanding | 6.03M |
| Shares Change (YoY) | +336.69% |
| Shares Change (QoQ) | +4.22% |
| Owned by Insiders (%) | 20.34% |
| Owned by Institutions (%) | 1.16% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -3.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -645.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 278.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$994,417 |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.48% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 48.50 |
| Average Volume (20 Days) | 9,414 |
Short Selling Information
The latest short interest is 9,106, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 9,106 |
| Short Previous Month | 84,728 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.90% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.57M |
| Pretax Income | -8.98M |
| Net Income | -7.96M |
| EBITDA | n/a |
| EBIT | -7.57M |
| Earnings Per Share (EPS) | -$1.43 |
Full Income StatementBalance Sheet
The company has $513,443 in cash and $2.19 million in debt, giving a net cash position of -$1.67 million or -$0.28 per share.
| Cash & Cash Equivalents | 513,443 |
| Total Debt | 2.19M |
| Net Cash | -1.67M |
| Net Cash Per Share | -$0.28 |
| Equity (Book Value) | -2.71M |
| Book Value Per Share | -0.44 |
| Working Capital | -2.71M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |